MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Deep brain stimulation (DBS)"

  • 2025 International Congress

    Nutrition, Motor And Non-Motor Symptoms Impact On Life’s Quality In Parkinson’s Disease In Second-Line Therapies

    N. Ayo Mentxakatorre, M. Acera Gil, C. Juanes, B. Tijero, M. Ruiz-Lopez, T. Fernandez-Valle, J. Gomez-Esteban, R. Del Pino (Barakaldo, Spain)

    Objective: Analyze the nutritional status, motor and non-motor symptoms of patients with Parkinson´s disease (PD) with second-line therapies [levodopa carbidopa intestinal gel (LCIG) and deep…
  • 2025 International Congress

    Unraveling the Intertwined Relationship of DBS, Parkinson’s Disease Subtype and LEDD: A Retrospective Study

    T. Mehta, V. Lavu, C. Hess, A. Ramirez-Zamora, M. Okun, J. Wong (Gainesville, USA)

    Objective: To assess the impact of deep brain stimulation (DBS) target and Parkinson’s disease (PD) motor subtype on the total levodopa equivalent daily dose (LEDD)…
  • 2025 International Congress

    Neurocognitive Functioning and Neurobehavioral Alterations in a Group of Patients Diagnosed with Idiopathic Parkinson’s Disease Without Dementia by Deep Brain Stimulation. Descriptive Study of the ESDEPARK Scale.

    C. Alberto Hurtado-González, J. Felipe Ayala-Rico, S. Ospina-Otalvaro, P. Gutiérrez-Lenis, A. Lucumi Moreno, M. Cañas-Lucendo, D. Reyes-Torres, L. Villegas-Trujillo, S. Ordoñez-Cure, K. Rivera-Quintero (Cali, Colombia)

    Objective: To identify the clinical correlation between neurocognitive functioning and depressive symptomatology in patients with IPDWD, assessed by a new scale (ESDEPARK) that measures depression…
  • 2025 International Congress

    Rapid Neurologic Decline after Subthalamic Nucleus Deep Brain Stimulation in Leucine-Rich Repeat Kinase 2 Parkinson’s disease (LRRK2-PD)

    T. Haddad, M. Rochman, TW. Liang (Phialdelphia, USA)

    Objective: To describe the clinical outcomes of two unrelated patients with LRRK2-PD who experienced rapid neurologic decline following subthalamic nucleus deep brain stimulation (STN-DBS). Background:…
  • 2025 International Congress

    Symptomatic Peri-Lead Oedema After Bilateral Subthalamic Nucleus Deep Brain Stimulation Surgery- Not All Cases Are Self-Limiting: A Case Series

    SS. Idris, O. Parras Granero, A. Chari, M. Krueger, H. Akram, J. Hyam, T. Foltynie, L. Zrinzo, P. Limousin (London, United Kingdom)

    Objective: To share 3 cases presented with seizure and encephalopathy after bilateral subthalamic nucleus deep brain stimulation surgery for Parkinson’s disease that requires removal of…
  • 2025 International Congress

    DBS Withdrawal Syndrome in Advanced Parkinson’s Disease: A Case Series

    H. Omercikoglu Ozden, S. Irmak, D. Gunal (İstanbul, Turkey)

    Objective: Deep Brain Stimulation (DBS) is a widely used neuromodulation therapy for managing motor complications in advanced Parkinson’s disease (PD). However, abrupt cessation of DBS,…
  • 2025 International Congress

    Basal Ganglia Neurophysiological Activity Associated with Depression in Parkinson’s Disease

    K. Johnson, P. Coutinho, L. Kenney, J. Wong, J. Hilliard, K. Foote, D. Bowers, G. Pontone, C. de Hemptinne (Gainesvile, USA)

    Objective: The objective of this study was to identify neurophysiological activity in the basal ganglia associated with depression in patients with Parkinson’s disease (PD) undergoing…
  • 2025 International Congress

    Does 10-year STN-DBS impact the natural progression of Parkinsons Disease? A Multicenter Retrospective Controlled Observational Study

    A. Gozzi, S. Convenga, L. Romito, F. Bove, F. Cavallieri, E. Scelzo, R. Cilia, R. Eleopra, V. Fraix, A. Castrioto, AR. Bentivoglio, C. Piano, I. Isaias, A. Priori, M. Sensi, D. Azzolina, P. Pellissier, S. Meoni, E. Moro (Grenoble, France)

    Objective: to evaluate the long-term risk of wheelchair confinement and motor function in Parkinson’s disease (PD) patients undergoing subthalamic deep brain stimulation (STN-DBS), compared to…
  • 2025 International Congress

    Using Chronic DBS Brain Sensing Data to Develop an AI-based Engine for Clinical Insights

    E. Fehrmann, A. Nourmohammadi, R. Molina, C. Zarns, M. Case, A. Becker, R. Raike (Minneapolis, USA)

    Objective: Our aim is to build an AI-based algorithm engine to deliver brain sensing-based data insights from deep brain stimulation (DBS) therapy systems that are…
  • 2025 International Congress

    Long-term results of pallidal deep brain stimulation in patients with Huntington’s disease

    A. Gamaleya, A. Poddubskaya, S. Asriyants, A. Tomskiy (Moscow, Russian Federation)

    Objective: To analyze long-term results of pallidal (GPi) deep brain stimulation (DBS) in patients with Huntington's disease (HD). Background: In HD, DBS is suggested to…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 169
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley